Y. John Lu, Partner , Milbank LLP
Dr. Lu’s practice focuses on patent, trade secrets, and life sciences litigation. He has represented clients in matters involving patent infringement, US-China trade secret misappropriation, biosimilars, ANDA litigation, and licensing disputes. Dr. Lu also represents clients in connection with proceedings before the Patent Trial and Appeal Board. His clients have included Genentech, Natera, Rosenberger, Biogen, and Gilead.
Dr. Lu is on the editorial advisory board for Law360 Life Science publications and was named to Benchmark Litigation’s “40 and Under Hot List”, which honors the achievements of the nation’s most accomplished litigators under 40. He was also named to the Southern California Rising Stars list by Super Lawyers 2019 – 2021.
Dr. Lu has also authored a number of publications, including: “Thryv: opposing policies in the Supreme Court,” World Intellectual Property Review (June 5, 2020); “The Growth of Online Universities: How to Solve the Accreditation Dilemma, Protect Students, and Expand Access to Higher Education,” chapter in Education and Social Media: Toward a Digital Future, MIT Press (2016); “Senate Gridlock Causes En Banc Uncertainty,” Intellectual Property Special Report, The Recorder (July 15, 2013); and “Promotion and Market Share in the Proton Pump Inhibitor Market: A Case Study,” Journal of Pharmaceutical Marketing & Management, Volume 17, Issue 3, 39-59 (2007).
Dr. Lu is currently the chair of the board of directors for Asian Pacific American Dispute Resolution Center (APADRC), a nonprofit organization. He was also a Fellow of the Leadership Council on Legal Diversity.
Prior to private practice, Dr. Lu was a law clerk to the Honorable William Alsup of the US District Court for the Northern District of California.
Dr. Lu received his J.D. from Yale Law School, where he was Notes Editor of the Yale Law Journal and Executive Editor of the Yale Journal of Law & Technology. While in law school, he was an extern for the Honorable John T. Noonan of the US Court of Appeals for the Ninth Circuit, and an intern for the US Attorney’s Office for the District of Connecticut.
Prior to law school, Dr. Lu earned his Doctor of Pharmacy, with highest distinction, from the University of North Carolina, and worked in pharmaceutical marketing.
Dr. Lu is conversant in Mandarin Chinese.